Biologic Drugs

May 02, 2012
Pharmaceutical Technology
Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.
May 02, 2012
PTSM: Pharmaceutical Technology Sourcing and Management
The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.
May 01, 2012
Pharmaceutical Technology
In this technical forum, experts describe different methods of rapid microbial testing and their applications.
Apr 05, 2012
ePT--the Electronic Newsletter of Pharmaceutical Technology
On Mar. 29, 2012, the Generic Pharmaceutical Association reiterated its call for Congress to move forward with user-fee proposals for generic drugs and biosimilar products.
Apr 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
How to use geographic diversification and legacy technology transfers to avoid product shortages.
Apr 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
With financing constrained, biotechnology firms must find ways to sustain innovation.
Apr 02, 2012
Pharmaceutical Technology
By Pharmaceutical Technology Editors
In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities.
Mar 15, 2012
ePT--the Electronic Newsletter of Pharmaceutical Technology
On Mar. 7, 2012, GE Healthcare announced an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, for an undisclosed amount.
Mar 02, 2012
Pharmaceutical Technology
Has the long-awaited guidance answered all of the industry's questions?
Mar 02, 2012
Pharmaceutical Technology
The divide between innovation and conflict of interest in medical research is not so clear.
native1_300x100
lorem ipsum